IRIDEX Corporation (IRIX) financial statements (2020 and earlier)

Company profile

Business Address 1212 TERRA BELLA AVE
MOUNTAIN VIEW, CA 94043
State of Incorp. DE
Fiscal Year End December 31
SIC 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments13212224101313
Cash and cash equivalents13212224101313
Receivables99810987
Inventory, net of allowances, customer advances and progress billings8991211911
Inventory8991211911
Deferred tax assets    2 
Other undisclosed current assets0110011
Total current assets:31403946313332
Noncurrent Assets
Operating lease, right-of-use asset3
Property, plant and equipment1112111
Intangible assets, net (including goodwill)1111111
Goodwill1111111
Intangible assets, net (excluding goodwill)0000000
Other noncurrent assets0000000
Deferred tax assets, net   97 
Total noncurrent assets:42221192
TOTAL ASSETS:35424248424234
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities7866656
Accounts payable3322222
Accrued liabilities2322222
Employee-related liabilities2322222
Taxes payable     00
Deferred revenue1
Debt1      
Deferred revenue and credits31111
Customer advances and deposits   1
Contract with customer, liability2
Other undisclosed current liabilities01211(0)0
Total current liabilities:1011108777
Noncurrent Liabilities
Long-term debt and lease obligation2      
Operating lease, liability2
Liabilities, other than long-term debt11111 0
Accounts payable and accrued liabilities000    
Deferred revenue0
Other liabilities00111 0
Other undisclosed noncurrent liabilities     1 
Total noncurrent liabilities:2111110
Total liabilities:1212119888
Stockholders' equity
Stockholders' equity attributable to parent23303139343426
Common stock0000000
Additional paid in capital73725955383941
Accumulated other comprehensive income00     
Accumulated deficit(51)(42)(29)(16)(4)(5)(15)
Total stockholders' equity:23303139343426
TOTAL LIABILITIES AND EQUITY:35424248424234

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues43434246424338
Cost of revenue(26)(25)(26)(25)(22)(21)(20)
Gross profit:18171621202119
Operating expenses(27)(30)(28)(23)(20)(19)(16)
Operating income (loss):(9)(13)(13)(3)033
Nonoperating income (expense)00(0)(0)0  
Interest and debt expense      (0)
Income (loss) from continuing operations before equity method investments, income taxes:(9)(13)(13)(3)032
Other undisclosed loss from continuing operations before income taxes     (1) 
Income (loss) from continuing operations before income taxes:(9)(13)(13)(3)012
Income tax expense (benefit)(0)(0)0(9)09(0)
Net income (loss) available to common stockholders, diluted:(9)(13)(13)(12)0102

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(9)(13)(13)(12)0102
Other comprehensive income00     
Comprehensive income (loss), net of tax, attributable to parent:(9)(13)(13)(12)0102

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: